ArticleEClinicalMedicine2025

Comparative therapeutic efficacy and safety of first-line and second-line therapies for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Bohao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.